Methanesulfonic Acid → Linaprazan mesylate
Reaktionsgleichung
[CH3:1][C:2]1[N:3]=[C:4]2[C:9]([NH:10][CH2:11][C:12]3[C:17]([CH3:18])=[CH:16][CH:15]=[CH:14][C:13]=3[CH3:19])=[CH:8][C:7]([C:20]([NH:22][CH2:23][CH2:24][OH:25])=[O:21])=[CH:6][N:5]2[C:26]=1[CH3:27].[CH3:28][S:29]([OH:32])(=[O:31])=[O:30]>C(O)C>[S:29]([OH:32])(=[O:31])(=[O:30])[CH3:28].[CH3:1][C:2]1[N:3]=[C:4]2[C:9]([NH:10][CH2:11][C:12]3[C:17]([CH3:18])=[CH:16][CH:15]=[CH:14][C:13]=3[CH3:19])=[CH:8][C:7]([C:20]([NH:22][CH2:23][CH2:24][OH:25])=[O:21])=[CH:6][N:5]2[C:26]=1[CH3:27]Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Reaktionsbedingungen
- Temperatur
- 10 °C
Versuchsvorschrift
75 g 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide was suspended in 350 ml ethanol and cooled to 10° C. 21.9 g methanesulfonic acid, diluted with 56 ml ethanol was charged. After rinsing with ethanol (44 ml), the suspension was stirred until conversion to 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt form B was complete. The crystals of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-N-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt form B were isolated and vacuum dried at 30° C. over night. Yield 99%.
Aufarbeitung
- additionwas charged
- washAfter rinsing with ethanol (44 ml)
Quellen und Nachweise
- ORD-Eintrag
- ord-4b2e14b567044683b83d21e7592c3080
- Quelldatensatz
- uspto-grants-2008_12
- Patentnummer
- US07459463B2
Notizen zur Reaktion
Wird geladen…